Über uns
Dr Laura Kenny is a Consultant in Medical Oncology and she specialises in breast cancer. She trained in medicine at Queen's University Belfast and after following initial registrar training, she moved to London to study for a PhD in translational molecular imaging in the Cyclotron Building, Imperial College London. Her NHS clinical practice is based at Charing Cross and Hammersmith Hospitals (part of Imperial College Healthcare NHS Trust) and she also sees patients privately. In addition, Dr Kenny is a Clinical Senior Lecturer at Imperial College.
Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.
She was awarded a prestigious NIHR/MRC clinician scientist fellowship in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents. Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.
Dr Kenny was also appointed as Director of Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK.
Diseases, Medical Tests and Treatments
Chemotherapy
Breast Cancer
Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.
She was awarded a prestigious NIHR/MRC clinician scientist fellowship in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents. Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.
Dr Kenny was also appointed as Director of Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK.
Diseases, Medical Tests and Treatments
Chemotherapy
Breast Cancer
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Laura Kenny
Ausbildung & Training
-
2008–2014 MD · Medicine and Surgery
-
2014–2018 Residency · Onkologie
-
2018–2019 Fellowship · Subspecialty training
Karriere & Anstellungen
-
2018-09–2019-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
GB — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
HDI Global · 3,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 86 |
| Annual physical exam | 99395 | 1,496 |
| Vaccination administration | 90471 | 1,856 |
| Minor procedure (skin) | 17110 | 879 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 Min. | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 Min. | in_clinic | 450.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 19 · i10: 11
-
European registry analysis of Onkologie outcomes
DOI: 10.3003/euroclin.2025.0 · PMID: 31994736 · zitiert von 22
-
Outcomes of Onkologie in adults — a multi-centre cohort
DOI: 10.2344/euroclin.2024.1 · PMID: 36057179 · zitiert von 116
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · London · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — London · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2019
- national college of family doctors — Member · Seit 2019
- European Union of Medical Specialists (UEMS) — Member · Seit 2019
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · dr.laura.kenny@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Ähnliche Spezialisten
Alle durchsuchen →
Mr Abdulla Alhasso
Onkologie · Glasgow
Dr Alexander McDonald
Onkologie · Glasgow
Dr Amna Sheri
Onkologie · London
Dr Angus Robinson
Onkologie · Horley
Dr Anne Armstrong
Onkologie · Manchester
Dr Ashraf Azzabi
Onkologie · Washington
Dr Clare Green
Onkologie · Winchester
Dr Desmond Yip
Onkologie · Garran